Page 1037

in the settlement agreement under AGC v. Washington State Health Care 1 Authority, Thurston county superior court no. 21-2-00479-34. 2 (((89))) (88) $38,230,000 of the general fund—state appropriation 3 for fiscal year 2022 and $18,188,000 of the general fund—state 4 appropriation for fiscal year 2023 are provided solely for claims for 5 services rendered to medicaid eligible clients admitted to 6 institutions of mental disease that were determined to be unallowable 7 for federal reimbursement due to medicaid's institutions for mental 8 disease exclusion rules. Of these amounts, $20,042,000 of the general 9 fund—state appropriation for fiscal year 2022 is provided solely for 10 belated claims for services that were rendered prior to fiscal year 11 2022. 12 (((90))) (89) $6,010,000 of the general fund—state appropriation 13 for fiscal year 2023 and $990,000 of the general fund—federal 14 appropriation are provided solely for the authority, in coordination 15 with the department of health, to deploy an opioid awareness campaign 16 and to contract with syringe service programs and other service 17 settings assisting people with substance use disorders to: Prevent 18 and respond to overdoses; provide other harm reduction services and 19 supplies, including but not limited to distributing naloxone, 20 fentanyl, and other drug testing supplies; and for expanding 21 contingency management services. The authority is encouraged to use 22 these funds to leverage federal funding for this purpose to expand 23 buying power. The authority should prioritize funds for naloxone 24 distribution for programs or settings that are least likely to be 25 able to bill medicaid. Of the amounts provided in this subsection, 26 $1,000,000 of the general fund—state appropriation for fiscal year 27 2023 is provided solely for the authority to deploy an opioid 28 awareness campaign targeted at youth to increase the awareness of the 29 dangers of fentanyl. Any moneys deposited into the general fund 30 pursuant to section 126(41) of this act from the Purdue Pharma and 31 Sackler family settlement must be used for the purposes of this 32 subsection. 33 (((91))) (90) $2,382,000 of the general fund—state appropriation 34 for fiscal year 2023 and $6,438,000 of the general fund—federal 35 appropriation are provided solely ((for a transition to bundled 36 payment arrangement methodology for opioid treatment providers. 37 Within these amounts, providers will receive a rate increase through 38 the new methodology and the)) to increase rates for opioid treatment 39 p. 1036 ESSB 5187.SL